Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis - Charbonnier, BA; Fiessinger, JN; Banga, JD; Wenzel, E; d’Azemar, P; Sagnard, L; on behalf the FRAXODI group. (Thromb Haemost, 1998)